ZENTALIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98943L907. A total of 4 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $240 | +37.9% | 12,000 | +93.5% | 0.00% | – |
Q2 2023 | $174 | +117.5% | 6,200 | +31.9% | 0.00% | – |
Q1 2023 | $80 | -52.1% | 4,700 | -43.4% | 0.00% | – |
Q4 2022 | $167 | -99.9% | 8,300 | -9.8% | 0.00% | – |
Q3 2022 | $199,000 | +73.0% | 9,200 | +124.4% | 0.00% | – |
Q2 2022 | $115,000 | -92.2% | 4,100 | -87.1% | 0.00% | -100.0% |
Q1 2022 | $1,467,000 | +142.5% | 31,800 | +341.7% | 0.00% | 0.0% |
Q4 2021 | $605,000 | +5950.0% | 7,200 | +3500.0% | 0.00% | – |
Q3 2021 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2021 | $10,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 4,700 | $80 | 0.00% |
JANE STREET GROUP, LLC | 16,400 | $282,080 | 0.00% |